STOCK TITAN

Logicbio Therapeutics (LOGC) Stock News

LOGC Nasdaq

Welcome to our dedicated page for Logicbio Therapeutics news (Ticker: LOGC), a resource for investors and traders seeking the latest updates and insights on Logicbio Therapeutics stock.

ContextLogic Holdings Inc. reports developments as a publicly traded business ownership platform focused on acquiring and building a portfolio of niche, competitively advantaged, long-duration businesses. News about ContextLogic centers on the completed acquisition of US Salt, operating and financial results, acquisition strategy, cash and investment resources, and the company’s evolution into a portfolio ownership model.

Company updates also cover governance and capital-structure matters, including board appointments, audit committee membership, shareholder voting, Delaware reorganization actions, strategic investment arrangements, and securities registration matters. The recurring themes are portfolio ownership, acquisition execution, operating efficiency, and public-company governance.

Rhea-AI Summary

ContextLogic (OTCQB: LOGC) agreed for its subsidiary GCH Buyer to acquire the holding company of specialty chemicals producer gChem from EagleTree Capital funds and co-investors at an enterprise value of $850 million. Upon closing, gChem will become ContextLogic's second operating business after US Salt.

gChem, a vertically integrated dimethyl sulfoxide leader with a Tuscaloosa manufacturing complex, will continue under CEO Frank Roederer, who signed a new five-year agreement. The Transaction and expenses are expected to be funded by up to $870 million of committed equity financing, a proposed fully backstopped rights offering at $9.00 per unit, and $275 million of committed debt (a $250 million term loan and $25 million revolver) led by Blackstone Credit & Insurance.

According to ContextLogic, after the Transaction and equity financing it expects about 174 million units of ContextLogic Holdings outstanding and combined 2027 free cash flow of $95–$105 million, and characterizes the deal as materially accretive to free cash flow per unit. Closing is targeted by year-end 2026, subject to customary approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.77%
Tags
-
Rhea-AI Summary

ContextLogic (OTCQB: LOGC) appointed former Grant Thornton CEO Seth Siegel as Senior Advisor, effective July 13, 2026. He will advise the company and its Board on strategic growth initiatives, transaction evaluation, financial reporting and governance as ContextLogic expands its business ownership platform.

According to ContextLogic, Siegel brings three decades of experience leading large, complex organizations, including overseeing double-digit organic revenue growth, record earnings and a landmark private equity investment at Grant Thornton. He is a licensed CPA, has SEC and PCAOB expertise, is qualified as an audit committee financial expert, and has personally invested in ContextLogic shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
none
-
Rhea-AI Summary

ContextLogic Holdings (OTCQB: LOGC) appointed Scott Stewart as Chief Financial Officer and Chief Operating Officer, effective June 1, 2026. The role combines oversight of finance and operations.

Stewart previously served as CFO of Cantaloupe and spent 13 years at Intercontinental Exchange, supporting 30+ acquisitions, including the NYSE deal. He earlier worked at Ernst & Young and holds accounting degrees from Clemson University.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.78%
Tags
none
Rhea-AI Summary

ContextLogic Holdings (OTCQB: LOGC) published a Q&A on its website following first quarter 2026 financial results. Shareholders and other interested parties submitted written questions to the investor relations inbox, and the company provided consolidated responses where possible.

Certain competitively sensitive or premature questions were not addressed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.39%
Tags
-
Rhea-AI Summary

ContextLogic (OTCQB: LOGC) reported first-quarter 2026 results, its first period including the US Salt acquisition. Combined non-GAAP revenue was $32.4 million, essentially flat year over year.

Combined non-GAAP net income rose to $17.0 million, aided by a $41.9 million tax benefit, while adjusted EBITDA was $11.6 million and free cash flow was negative $20.6 million, reflecting significant acquisition-related transaction expenses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.8%
Tags
-
Rhea-AI Summary

ContextLogic (OTCQB: LOGC) announced on April 1, 2026 that Paul S. Levy has been appointed an independent director and named to the Audit Committee. Mr. Levy, founder of JLL Partners in 1988, brings forty years of private equity and board experience and will waive director compensation.

He is a significant shareholder and has served on boards including Loar Holdings and Builders FirstSource, with earlier roles at Drexel Burnham Lambert and as CEO of Yves Saint Laurent. Mr. Levy holds degrees from Lehigh University and the University of Pennsylvania Law School.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.5%
Tags
management
Rhea-AI Summary

ContextLogic (OTCQB: LOGC) reported fourth-quarter and fiscal year 2025 results and completed a strategic acquisition. The company completed the previously announced $907.5 million acquisition of US Salt on February 26, 2026, positioning ContextLogic as a business ownership platform focused on niche, long-duration businesses.

Q4 net loss was $13 million versus $2 million in Q4 2024. As of December 31, 2025, cash and equivalents were $77 million and marketable securities $141 million, with consolidated cash, equivalents and securities of approximately $218 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.15%
Tags
-
Rhea-AI Summary

ContextLogic (OTCQB: LOGC) completed acquisition of US Salt for an enterprise value of approximately $907.5 million on February 26, 2026, transforming into a business ownership platform. The transaction combines ContextLogic’s ~$2.9 billion net operating loss carryforwards with US Salt’s cash-generating business.

Financing included ~$292 million cash from ContextLogic (including $150 million from a fund advised by BC Partners Credit), committed debt ($215 million term loan and $25 million revolver), a $115 million rights offering, and ~$325 million of rollover equity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
-
Rhea-AI Summary

ContextLogic (OTCQB: LOGC) launched a fully backstopped $115 million rights offering at $8.00 per share to fund its previously announced $907.5 million acquisition of US Salt. The Company is offering up to 14,375,000 new shares (about 20.9% of post-transaction share capital if fully subscribed); if fully subscribed ContextLogic would own 67.8% of the units of ContextLogic Holdings, LLC. The Rights Offering is effective Jan 22, 2026 with an expiration of Feb 20, 2026 at 5:00 PM ET, a subscription ratio of 0.53486 rights per share, and an estimated transaction close of Feb 26, 2026. The offering is fully backstopped by Abrams Capital and BC Partners Credit and includes a 4.9% ownership cap to preserve approximately $2.9 billion of NOLs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
Rhea-AI Summary

ContextLogic (OTCQB: LOGC) agreed to acquire US Salt for an enterprise value of $907.5 million, marking its shift into a business ownership platform focused on niche, long-duration businesses. The deal finances include $292M cash, a $215M term loan and $25M revolver led by Blackstone Credit, plus expected $115M from a rights offering fully backstopped by Abrams Capital and BC Partners Credit. Abrams will roll over about $315M of equity and become the largest shareholder; closing is expected in H1 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.11%
Tags
partnership acquisition

FAQ

What is the current stock price of Logicbio Therapeutics (LOGC)?

The current stock price of Logicbio Therapeutics (LOGC) is $10.5 as of August 12, 2026.

What is the market cap of Logicbio Therapeutics (LOGC)?

The market cap of Logicbio Therapeutics (LOGC) is approximately 216.4M.